Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

PACS (PACS) Shares Outstanding (Weighted Average): 2023-2025

Historic Shares Outstanding (Weighted Average) for PACS (PACS) over the last 3 years, with Q3 2025 value amounting to $156.6 million.

  • PACS's Shares Outstanding (Weighted Average) rose 225.36% to $156.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $156.6 million, marking a year-over-year increase of 225.36%. This contributed to the annual value of $146.7 million for FY2024, which is 1393.68% up from last year.
  • According to the latest figures from Q3 2025, PACS's Shares Outstanding (Weighted Average) is $156.6 million, which was up 225.36% from $156.3 million recorded in Q2 2025.
  • In the past 5 years, PACS's Shares Outstanding (Weighted Average) registered a high of $156.6 million during Q3 2025, and its lowest value of $128.7 million during Q1 2023.
  • For the 3-year period, PACS's Shares Outstanding (Weighted Average) averaged around $143.2 million, with its median value being $148.1 million (2024).
  • As far as peak fluctuations go, PACS's Shares Outstanding (Weighted Average) changed by 0.0% in 2024, and later soared by 2055.11% in 2025.
  • Over the past 3 years, PACS's Shares Outstanding (Weighted Average) (Quarter) stood at $128.7 million in 2023, then increased by 13.94% to $146.7 million in 2024, then rose by 6.76% to $156.6 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $156.6 million for Q3 2025, versus $156.3 million for Q2 2025 and $155.2 million for Q1 2025.